Through interacting with PRMT5 (arginine methyltransferase 5) and blocking ubiquitin/proteasome dependent degradation to enhance its protein stability, LINCO1138 acts as an oncogenic driver in HCC [28]. The gene discussed is PRMT5; the disease is hepatocellular carcinoma.